VANI - NASDAQ

Vivani Medical, Inc.

Vivani Medical, Inc.

VANI·NASDAQ

$1.28

-0.78%
HealthcareMedical - Devices

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$75.62M
EPS-0.4300
P/E Ratio-2.98
Earnings Date08/12/2026

Available Earnings Call Transcripts

Select a year and quarter to view the full transcript.

Vivani Medical, Inc.

Vivani Medical, Inc. Earnings Call Transcripts

VANI · NASDAQ

Related Guides

Blog Categories

Continue your VANI research with focused valuation guides.

Forecasting

Compare management guidance with modeled outcomes.

Risk Analysis

Track estimate risk, misses, and downside scenarios.

Reference

Review analyst process and transcript interpretation.

Value Investing

Anchor quarterly narrative to intrinsic value discipline.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.